🔎 Trials Near Me

መነሻ › ከመጠን በላይ ክብደት › አሪዞና › Phoenix

በPhoenix፣ AZ ለከመጠን በላይ ክብደት የሚደረጉ ክሊኒካዊ ጥናቶች

ለከመጠን በላይ ክብደት የሚደረጉ 15 ጥናቶች በPhoenix እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Absolute Clinical Research, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • RIO Clinical Trials - Phoenix, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Synexus Clinical Research US, Inc., Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
እድሜ ከ45 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Elite Clinical Studies, LLC, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AURORA-1 Clinical Site, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • AURORA-2 Clinical Site, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07743450

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Helios Clinical Research - Phoenix, Phoenix
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3ጤናማ ተሳታዮች ይቀበላሉ
  • ACCOMPLISH-2 Research Site, Phoenix
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Synexus Clinical Research US, Inc., Phoenix
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Medical Dermatology Specialists, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Kailera Clinical Site, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07284901

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Exponent Phoenix, Phoenix
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07776678

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • ACCOMPLISH-1 Research Site, Phoenix
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT07654361

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • The University of Arizona College of Medicine- Phoenix, Phoenix
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኖቬም 2025 · NCT06499857

በሌሎች ከተሞች ለከመጠን በላይ ክብደት የሚደረጉ ጥናቶች

በPhoenix ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።